|
|
|
Insider
Information: |
Martin John C |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,895,138 |
|
Indirect Shares
|
2,684,281 |
|
|
Direct
Value |
$189,361,486 |
|
|
Indirect Value
|
$47,757,584 |
|
|
Total
Shares |
5,579,419 |
|
|
Total
Value |
$237,119,070 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
President and CEO |
|
2007-04-10 |
4 |
AS |
$78.00 |
$2,735,434 |
D/D |
(35,000) |
737,629 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2007-05-08 |
4 |
OE |
$2.86 |
$100,079 |
D/D |
35,000 |
772,629 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2007-05-08 |
4 |
AS |
$82.00 |
$2,875,751 |
D/D |
(35,000) |
737,629 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2007-06-12 |
4 |
AS |
$78.84 |
$2,761,035 |
D/D |
(35,000) |
737,629 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2007-06-12 |
4 |
OE |
$2.86 |
$100,079 |
D/D |
35,000 |
772,629 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2008-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
1,553,457 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
1,612,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-03-12 |
4 |
D |
$46.16 |
$1,616,062 |
D/D |
(35,010) |
1,989,205 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-03-15 |
4/A |
D |
$39.79 |
$1,519,978 |
D/D |
(38,200) |
1,948,483 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2003-11-04 |
4 |
OE |
$5.63 |
$225,000 |
D/D |
40,000 |
350,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2003-11-04 |
4 |
S |
$54.56 |
$2,199,895 |
D/D |
(40,000) |
310,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2004-05-03 |
4 |
S |
$60.46 |
$2,429,290 |
D/D |
(40,000) |
335,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2004-05-03 |
4 |
OE |
$5.63 |
$225,000 |
D/D |
40,000 |
339,290 |
|
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
40,010 |
3,037,116 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
President and CEO |
|
2007-12-04 |
4 |
OE |
$3.65 |
$155,546 |
D/D |
42,408 |
1,518,457 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
officerTitle |
|
2005-12-21 |
4 |
OE |
$2.86 |
$139,686 |
D/D |
44,640 |
728,217 |
|
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-12-01 |
4 |
OE |
$8.22 |
$367,545 |
D/D |
44,720 |
1,993,935 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-12-01 |
4 |
AS |
$40.01 |
$1,789,068 |
D/D |
(44,720) |
1,949,215 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-12-05 |
4 |
AS |
$40.00 |
$1,852,000 |
D/D |
(46,300) |
1,949,215 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-12-05 |
4 |
OE |
$8.22 |
$380,530 |
D/D |
46,300 |
1,995,515 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
officerTitle |
|
2003-08-08 |
4 |
OE |
$3.50 |
$238,750 |
D/D |
50,000 |
340,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
officerTitle |
|
2003-08-08 |
4 |
S |
$62.28 |
$3,136,075 |
D/D |
(50,000) |
310,790 |
|
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-01-02 |
4 |
AS |
$72.26 |
$3,681,235 |
D/D |
(50,000) |
2,996,766 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-01-02 |
4 |
OE |
$23.60 |
$1,180,000 |
D/D |
50,000 |
3,046,766 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-02-01 |
4 |
AS |
$83.35 |
$4,177,824 |
D/D |
(50,000) |
2,996,766 |
0 |
- |
|
367 Records found
|
|
Page 3 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|